Co-Diagnostics, Inc. — Director's Dealing 2020

Nov 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2020-11-25

Reporting Person: BENSON REED L (CFO and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-25	Common Stock	M	100000	$1.10	Acquired	100000	Direct
2020-11-25	Common Stock	F	10476	$1.10	Disposed	89524	Direct
2020-11-25	Common Stock	S	89524	$10.50	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-25	Non-Qualified Stock Option (right to buy)	$1.10	M	100000	Disposed	2029-09-02	Common Stock (100000)	Direct

Footnotes

F1: Non-Qualified Stock Option granted to Reporting Person on September 3, 2019 pursuant to the Issuer's 2015 Long-Term Incentive Plan, as amended, to purchase up to 125,000 shares of common stock of the Issuer and previously reported on a Form 4 filed with the Commission on November 15, 2019.

F2: 100,000 of the Options have vested.

F3: Reflects 10,476 shares withheld by the Issuer at the market price of $10.50 per share less the exercise price of $1.10 per share to fund the cashless exercise of 100,000 options owned by the Reporting Person.